Aristotle Capital Boston’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.16M | Sell |
58,420
-11,057
| -16% | -$1.36M | 0.36% | 89 |
|
|
2025
Q1 | $7.04M | Sell |
69,477
-27,292
| -28% | -$2.76M | 0.35% | 88 |
|
|
2024
Q4 | $8.94M | Sell |
96,769
-8,218
| -8% | -$759K | 0.33% | 91 |
|
|
2024
Q3 | $10.1M | Sell |
104,987
-28,042
| -21% | -$2.71M | 0.34% | 90 |
|
|
2024
Q2 | $11.4M | Sell |
133,029
-34,136
| -20% | -$2.93M | 0.38% | 87 |
|
|
2024
Q1 | $13.8M | Sell |
167,165
-12,632
| -7% | -$1.04M | 0.42% | 87 |
|
|
2023
Q4 | $12M | Sell |
179,797
-22,729
| -11% | -$1.52M | 0.37% | 99 |
|
|
2023
Q3 | $13.6M | Sell |
202,526
-3,823
| -2% | -$257K | 0.44% | 87 |
|
|
2023
Q2 | $14M | Buy |
206,349
+9,010
| +5% | +$610K | 0.42% | 89 |
|
|
2023
Q1 | $10.7M | Buy |
197,339
+12,228
| +7% | +$662K | 0.33% | 105 |
|
|
2022
Q4 | $11.1M | Sell |
185,111
-7,013
| -4% | -$419K | 0.35% | 103 |
|
|
2022
Q3 | $8.69M | Sell |
192,124
-93,182
| -33% | -$4.21M | 0.29% | 114 |
|
|
2022
Q2 | $12.7M | Buy |
285,306
+25,553
| +10% | +$1.14M | 0.38% | 109 |
|
|
2022
Q1 | $14.7M | Buy |
259,753
+174
| +0.1% | +$9.84K | 0.37% | 109 |
|
|
2021
Q4 | $13.5M | Buy |
259,579
+30,170
| +13% | +$1.57M | 0.32% | 115 |
|
|
2021
Q3 | $13.7M | Buy |
229,409
+33,747
| +17% | +$2.01M | 0.32% | 112 |
|
|
2021
Q2 | $12.1M | Sell |
195,662
-4,586
| -2% | -$285K | 0.28% | 118 |
|
|
2021
Q1 | $13M | Buy |
200,248
+19,984
| +11% | +$1.3M | 0.29% | 115 |
|
|
2020
Q4 | $11.9M | Buy |
180,264
+25,163
| +16% | +$1.66M | 0.28% | 112 |
|
|
2020
Q3 | $8.02M | Buy |
155,101
+13,090
| +9% | +$677K | 0.23% | 116 |
|
|
2020
Q2 | $7M | Buy |
+142,011
| New | +$7M | 0.21% | 118 |
|